CureVac has been on the record as a pioneer in the mRNA therapeutics field since that first, groundbreaking work published by our co-founder, Dr. Hoerr in 2000—making us the world’s primary authors of mRNA therapeutic literature. We’re excited to share everything we’ve done using our mRNA platform to transform lives. Dive deep into the science of our technology—and all that’s possible with it—with publications written by CureVac team members.
Schlake et al.; Molecular Therapy, April 2019
Eigentler et al., presented at the American Association for Cancer Research Annual Meeting, March 2019.
Doener et al., Vaccine, March 2019.
Sebastian et al., Cancer Immunology, Immunotherapy, February 2019.
Papachristofilou et al., Journal for ImmunoTherapy of Cancer, 2019.
Rauch et al., Front. Immunol., September 2018.